Ligand validation:4CK0

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 4CK0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4CK0_OLC_B_1121	3%	95%	0.413	0.752	0.2	0.2	-	-	2	0	100%	1
4CK0_OLC_B_1122	2%	96%	0.51	0.796	0.18	0.18	-	-	2	0	100%	1
4UXX_OLC_B_1123	5%	95%	0.352	0.774	0.17	0.24	-	-	1	0	100%	1
4UXW_OLC_B_1123	5%	89%	0.36	0.776	0.31	0.32	-	-	2	0	100%	1
4CJZ_OLC_C_1120	1%	94%	0.41	0.632	0.19	0.23	-	-	1	0	100%	1
7YXA_OLC_A_2505	70%	60%	0.127	0.943	0.67	0.84	-	-	3	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.